Address nitrosamine risk mitigation with confidence

Discover co-innovation opportunities to develop nitrosamine-free pharmaceuticals

Global regulatory bodies, including the FDA and EMA, have introduced a legal obligation for drug manufacturers to implement mitigation strategies that aim to minimize the risk of nitrosamine formation in drug products. 

The addition of antioxidants to drug formulations is a safe and viable, FDA-recommended mitigation strategy for inhibition of nitrosamine formation in drug products. Prevention of formation of potentially carcinogenic impurities is possible with commonly used ascorbic acid and alpha-tocopherol

When added to your formulation as excipients, ascorbic acid and alpha-tocopherol bring multiple benefits, including:

  • Efficient nitrosamine inhibition
  • Acting as stabilizers in the finished drug product formulation.

Explore viable strategies to confidently address nitrosamine risk mitigation

Nitrosamine risk mitigation is a huge challenge for drug manufacturers and the wider pharmaceutical industry. Extensive formulation and regulatory knowledge as well as a comprehensive understanding of the active pharmaceutical ingredient (API) and manufacturing processes is crucial to bring safer drug products to market.

Discover how dsm-firmenich can help you navigate nitrosamine risk mitigation through our reliable customized solutions and expert services.

eChalk Talk

Nitrite Scavengers - An Elegant and Simple Solution to Mitigate Nitrosamines in Drug Products

With looming deadlines set by governmental bodies, all pharmaceutical companies must assess and control nitrosamine content in their drug products. Solutions are often multi-layered and may include simple and safe nitrite scavengers in the final drug formulation. In this AAPS e-chalk talk dsm-firmenich experts discuss key considerations for nitrosamine mitigation in drug products using nitrite scavengers.

Learning objectives:

  • Learn about nitrite scavengers of use for nitrosamine mitigation in drug products
  • Better understanding of key aspects when formulating with ascorbic acid and alpha-tocopherol
  • Case studies

This session lasts 30 min.

Explore the latest science on nitrosamine mitigation with our whitepaper and webinar

Discover the benefits of ascorbic acid and alpha-tocopherol for nitrosamine-free formulations

Our latest whitepaper explores the current nitrosamine regulatory climate that the pharmaceutical market is facing. Formulators are now confronted with new guidelines that may lead to the reassessment of certain drug formulations at risk of nitrosamine formation. As a critical priority for global agencies, developing nitrosamine mitigation strategies is imperative for the safety of future pharmaceuticals. Ascorbic acid and alpha-tocopherol could be the answer to developing risk-free formulations. 

Webinar: Antioxidants as blocking agents for nitrosamine formation in drug products

Nitrosamines are potential mutagens and need to be controlled in human drug products. Recently, nitrosamine contamination of high-profile drugs has prompted numerous recalls, and increased regulatory assessments for marketed products, as well as for new drug applications. Learn from leading experts how antioxidants in drug formulation can minimize the risk of nitrosamine formation.

Think nitrosamine mitigation. Think DSM.

Overcoming critical formulation challenges takes more than adding ingredients – it takes a reliable partner. Whether it’s supporting you with the reformulation of your existing drug product, or helping to bring new innovative therapies to market, we can assist you in implementing a proven mitigation strategy to reduce the risk of nitrosamine formation in your pharmaceuticals.

Industry-leading API portfolio and advanced formulation expertise

DSM has more than 70 years of experience in producing and securing the supply of vitamin APIs and excipients. Manufactured in GMP-certified facilities, our pharmaceutical grade ascorbic acid and alpha-tocopherol excipients are ingredients you can trust.

Scientific knowledge

We have the scientific know-how and cutting-edge technology you need to mitigate the risk of nitrosamines in your oral solid, semisolid, liquid or injectable formulations.

Regulatory insight

Our excipient production is governed by a wide range of global certification systems to support the success of your pharmaceutical solutions, including GMP, CEPs, DMFs and compliance with multiple pharmacopeia.

Global reach

DSM is global company with a global footprint and strong local knowledge.

We are an ideal partner for purposeful improvements and advancements in the pharmaceutical space. To learn more about our advanced formulation expertise and solutions for nitrosamine mitigation, connect with one of our experts today. 

Personal Information

Company Information

Communication Preferences

We take your privacy very seriously. DSM will use the information you provide for an email newsletter and for general marketing purposes. You can unsubscribe at any time. 

I agree with DSM's User Terms and Conditions and acknowledge that DSM will process my personal data for the purposes described in its Privacy Policy.